𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Relative effectiveness of gemcitabine in the treatment for pancreatic cancer — A pragmatic approach

✍ Scribed by J. McKendrick; T. Duthie

Book ID
117667539
Publisher
Elsevier Science
Year
1999
Tongue
English
Weight
158 KB
Volume
35
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined gemcitabine and radioimmunother
Combined gemcitabine and radioimmunotherapy for the treatment of pancreatic cancer
✍ Thomas M. Cardillo; Rosalyn Blumenthal; Zhiliang Ying; David V. Gold 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 116 KB 👁 1 views

## Abstract MAb‐PAM4 is an anti‐MUC1 antibody that has been shown to be reactive with 85% of pancreatic adenocarcinomas with no reactivity with normal pancreas or other tissues. Initial clinical studies have shown excellent targeting with high tumor/nontumor ratios. Gemcitabine, an analog of deoxyc